- Home
- PHAT vs CCEC Comparison
PHAT vs CCEC Comparison
Compare PHAT & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | CCEC |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PHAT | CCEC |
|---|---|---|
| Price | $12.78 | $20.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $17.33 | ★ $25.50 |
| AVG Volume (30 Days) | ★ 1.1M | 4.4K |
| Earning Date | 03-05-2026 | 02-06-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | N/A | ★ 304.00 |
| EPS | N/A | ★ 4.79 |
| Revenue | $147,190,000.00 | ★ $421,795,000.00 |
| Revenue This Year | $221.87 | $14.29 |
| Revenue Next Year | $80.37 | $12.32 |
| P/E Ratio | ★ N/A | $4.27 |
| Revenue Growth | ★ 460.30 | 32.74 |
| 52 Week Low | $2.21 | $14.09 |
| 52 Week High | $18.31 | $24.83 |
Technical Indicators
Market Signals| Indicator | PHAT | CCEC |
|---|---|---|
| Relative Strength Index (RSI) | 38.22 | 42.60 |
| Support Level | $12.22 | $20.46 |
| Resistance Level | $14.53 | $22.58 |
| Average True Range (ATR) | 0.85 | 0.48 |
| MACD | -0.12 | -0.13 |
| Stochastic Oscillator | 23.22 | 1.42 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About CCEC Capital Clean Energy Carriers Corp.
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.